The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study
尼洛替尼治疗儿童慢性粒细胞白血病患者的长期疗效和安全性:DIALOG 研究的 5 年更新
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010122
Hijiya, Nobuko; Maschan, Alexey; Rizzari, Carmelo; Shimada, Hiroyuki; Dufour, Carlo; Goto, Hiroaki; Kang, Hyoung Jin; Guinipero, Terri; Karakas, Zeynep; Bautista, Francisco; Ducassou, Stéphane; Yoo, Keon Hee; Zwaan, Christian Michel; Millot, Frédéric; Patterson, Briana C; Samis, Jill; Izquierdo, Miguel; Titorenko, Ksenia; Li, Sai; Sosothikul, Darintr